Difficulty: Medium
Average Score: 71%
Practice
Which of the following sympathomimetics is preferable for the treatment of chronic orthostatic hypotension?
Correct answer
C
Rationale
In the context of safety pharmacology across the lifespan, it is crucial to understand the appropriate sympathomimetic agents for various conditions. In the case of chronic orthostatic hypotension, the preferable sympathomimetic is ephedrine (option C). Ephedrine acts by stimulating both alpha and beta adrenergic receptors, leading to vasoconstriction and increased heart rate, which are beneficial in addressing orthostatic hypotension.
Epinephrine (option A) is not the ideal choice for chronic orthostatic hypotension due to its potent vasoconstrictive effects, which can lead to increased systemic vascular resistance and potentially worsen the condition. Norepinephrine (option B) primarily acts on alpha receptors, leading to vasoconstriction without significant beta receptor stimulation, which may not effectively address the underlying issue of orthostatic hypotension.
Salmeterol (option D) is a long-acting beta agonist primarily used in respiratory conditions like asthma and COPD. It is not indicated for the treatment of orthostatic hypotension as it does not provide the necessary vasoconstrictive effects to address the condition effectively.
Understanding the mechanisms of action of sympathomimetic agents in the context of specific conditions like orthostatic hypotension is vital for safe and effective pharmacological management across the lifespan. It is essential for healthcare professionals to be able to differentiate between these agents to provide optimal care for patients with diverse pharmacological needs.
Epinephrine (option A) is not the ideal choice for chronic orthostatic hypotension due to its potent vasoconstrictive effects, which can lead to increased systemic vascular resistance and potentially worsen the condition. Norepinephrine (option B) primarily acts on alpha receptors, leading to vasoconstriction without significant beta receptor stimulation, which may not effectively address the underlying issue of orthostatic hypotension.
Salmeterol (option D) is a long-acting beta agonist primarily used in respiratory conditions like asthma and COPD. It is not indicated for the treatment of orthostatic hypotension as it does not provide the necessary vasoconstrictive effects to address the condition effectively.
Understanding the mechanisms of action of sympathomimetic agents in the context of specific conditions like orthostatic hypotension is vital for safe and effective pharmacological management across the lifespan. It is essential for healthcare professionals to be able to differentiate between these agents to provide optimal care for patients with diverse pharmacological needs.